Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
Post# of 49
Next 10
Reply Private New
Public Reply Private Reply New Post
Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

jondoeuk

Send PM
Followers 26
Posts 2469
Boards Moderated 1
Alias Born 10/24/2015

FREE
AUTL REPORT

jondoeuk

Re: None

Saturday, 11/16/2019 12:59:49 PM

Saturday, November 16, 2019 12:59:49 PM

Post# of 49
The company has inked an agreement with Noile-Immune Biotech for rights to develop certain CAR-T therapies using Noile's PRIME (PRoliferation-Inducing and Migration-Enhancing) tech secreting both IL-7 and CCL19.

Here is some preclinical data https://www.nature.com/articles/nbt.4086
Public Reply Private Reply New Post
Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AUTL News
More AUTL News
InvestorsHub NewsWire

FEATURED Tiziana Life Sciences Announces Anti-CD3 mAb Research for the Treatment of Alzheimer's Disease to be Presented by Dr. Howard Weiner at the International Conference on Alzheimer's and Parkinson's Disease and Related Neurological Disorders Conference • Mar 31, 2023 7:07 AM

ILUS Confirms Further Funding Arrangements and Note Settlement • ILUS • Mar 31, 2023 10:21 AM

Sigyn Therapeutics Announces Filing of 2022 Annual Report on SEC Form 10-K • SIGY • Mar 31, 2023 10:06 AM

ARway Secures Multiple New SDK Deals to Drive Growth in $44B Indoor Positioning and Navigation Market • ARWYF • Mar 30, 2023 10:30 AM

Nextech3D.ai Enters Asian Market with Major 3D Modeling Deal to Revolutionize E-Commerce • NTAR • Mar 30, 2023 10:00 AM

OMID Posts 2022 Annual Report and Provides Update • OMID • Mar 30, 2023 9:15 AM

Start posting your company's news
Only $200 per official company press release!